Uterine Fibroids Treatment Market Size, Share and Forecasts 2026
Uterine Fibroids Treatment Market is expected to grow at XX% CAGR during the forecast period 2019-2026
(EMAILWIRE.COM, September 09, 2019 ) Market Overview:
Uterine Fibroids are the most common benign, non-cancerous tumors of a womans uterus, most often seen during the childbearing years.Fibroids are only treated if they cause symptoms and treatment options to range from medications to invasive surgery.
Market Dynamics:
The market is primarily driven by increasing patient pool owing to increasing female geriatric population, growing prevalence of hormonal disorders and changing lifestyle. However, high R&D cost is likely to hinder market growth.
Market Segmentation:
The Uterine Fibroids Treatment market report segments the market by type, by treatment type, and by region.
Based on the type of fibroid, the market comprises of:
Subserosal Fibroids
Intramural Fibroids
Submucosal Fibroids
Pedunculated
Based on treatment type, the market is categorized into:
Hormone therapy
Gonadotropin-releasing hormone agonists
Uterine artery embolization
Myomectomy
Hysterectomy
Treatment options for traditional surgical procedures include abdominal myomectomy and hysterectomy. Other non-standard but new treatments available for uterine fibroids include Radiofrequency ablation and Anti-hormonal drugs.
Geographical Analysis:
Geographically, the market is segmented into five major regions, namely:
Asia Pacific (China, Japan, India, Australia, Rest of Asia Pacific)
Europe (Germany, France, The UK, Italy, Spain, Rest of Europe)
North America (The USA, Canada, Mexico)
South America (Brazil, Argentina, Rest of South America)
The Middle East
Competitive Analysis:
Key Players:
Allergan
Gedeon Richter
Repros
Bayer HealthCare
AbbVie
Others
View full report: https://www.datamintelligence.com/research-report/uterine-fibroids-treatment-market
Download free sample: https://www.datamintelligence.com/download-sample/uterine-fibroids-treatment-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Uterine Fibroids are the most common benign, non-cancerous tumors of a womans uterus, most often seen during the childbearing years.Fibroids are only treated if they cause symptoms and treatment options to range from medications to invasive surgery.
Market Dynamics:
The market is primarily driven by increasing patient pool owing to increasing female geriatric population, growing prevalence of hormonal disorders and changing lifestyle. However, high R&D cost is likely to hinder market growth.
Market Segmentation:
The Uterine Fibroids Treatment market report segments the market by type, by treatment type, and by region.
Based on the type of fibroid, the market comprises of:
Subserosal Fibroids
Intramural Fibroids
Submucosal Fibroids
Pedunculated
Based on treatment type, the market is categorized into:
Hormone therapy
Gonadotropin-releasing hormone agonists
Uterine artery embolization
Myomectomy
Hysterectomy
Treatment options for traditional surgical procedures include abdominal myomectomy and hysterectomy. Other non-standard but new treatments available for uterine fibroids include Radiofrequency ablation and Anti-hormonal drugs.
Geographical Analysis:
Geographically, the market is segmented into five major regions, namely:
Asia Pacific (China, Japan, India, Australia, Rest of Asia Pacific)
Europe (Germany, France, The UK, Italy, Spain, Rest of Europe)
North America (The USA, Canada, Mexico)
South America (Brazil, Argentina, Rest of South America)
The Middle East
Competitive Analysis:
Key Players:
Allergan
Gedeon Richter
Repros
Bayer HealthCare
AbbVie
Others
View full report: https://www.datamintelligence.com/research-report/uterine-fibroids-treatment-market
Download free sample: https://www.datamintelligence.com/download-sample/uterine-fibroids-treatment-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results